Karolinska Institutet
Browse

Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci and other bacteria : protective effect of antioxidants

thesis
posted on 2024-09-03, 01:02 authored by Rabea K L Bouhafs

Respiratory distress syndrome (RDS), caused by surfactant deficiency, is a leading cause of mortality and morbidity in preterm neonates. Further, infants with systemic neonatal infection or pneumonia often have signs of RDS. As neonatal infection and RDS may occur simultaneously, infants with infections may receive exogenous surfactant as treatment. Our hypothesis was that surfactant lipids are peroxidized by reactive oxygen species from phagocytes and bacteria and that Curosurf, a surfactant preparation given to newborn infants, may be improved by the addition of antioxidants to counteract toxic free radicals.

We studied superoxide production by bacteria and human neutrophils (PMN) by the nitroblue tetrazolium (NBT) test. Also, the nitric oxide (NO) production by rat alveolar macrophages (AM) was measured by Griess reaction. The lipid peroxidation (LPO) of surfactant (Curosurf) was determined as the level of malondialdehyde and 4-hydroxyalkenals. The impact of free radicals on surfactant function was estimated by measuring surface tension. The ability of different antioxidants in counteracting the LPO of surfactant was estimated in vitro. In vivo, we tested the effect of GBS infection and exogenous surfactant treatment in tracheotomized, ventilated, near-term newborn rabbits. Also, the effect of vitamin E as antioxidant was investigated.

Surfactant decreased the superoxide production by bacteria and PMN, as well as the NO production by AM. Surfactant was peroxidized when incubated with resting or with stimulated PMN or AM, but also with bacteria alone, and the LPO increased with time. Vitamin E supplementation decreased the LPO levels. Lung surfactant was bactericidal to group B streptococci (GBS) and Escherichia coli, but Pseudomonas aeruginosa was resistant. The biophysical activity of Curosurf was impaired by GBS-stimulated PMN, as reflected by an increased surface tension. All antioxidants (SOD, vitamin E, vitamin C, ebselen and melatonin) tested except vitamin C decreased superoxide production and surfactant peroxidation by PMN in a dose dependent manner. The best combination was that of a natural and a synthetic antioxidant (melatonin-ebselen). In the in vivo model we found that GBS infected rabbits had higher LPO of their lung lavage fluid than uninfected animals. The LPO level could be diminished by adding vitamin E to exogenous surfactant.

Our findings suggest that antioxidants supplementation can improve the surfactant therapy when given to infants with GBS pneumonia.

List of scientific papers

I. Bouhafs RK, Jarstrand C (1999). Phagocyte-induced lipid peroxidation of lung surfactant. Pediatr Pulmonol. 27(5): 322-7.
https://pubmed.ncbi.nlm.nih.gov/10344711

II. Bouhafs RK, Jarstrand C (1999). Lipid peroxidation of lung surfactant by bacteria. Lung. 177(2): 101-10.
https://pubmed.ncbi.nlm.nih.gov/9929407

III. Bouhafs RK, Jarstrand C (2000). Interaction between lung surfactant and nitric oxide production by alveolar macrophages stimulated by group B streptococci. Pediatr Pulmonol. 30(2): 106-13.
https://pubmed.ncbi.nlm.nih.gov/10922132

IV. Bouhafs RK, Rauprich P, Herting E, Schroder A, Robertson B, Jarstrand C (2000). Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci. Lung. 178(5): 317-29.
https://pubmed.ncbi.nlm.nih.gov/11147315

V. Bouhafs RK, Jarstrand C (2002). Effects of antioxidants on surfactant peroxidation by stimulated human polymorphonuclear leukocytes. Free Radic Res. 36(7): 727-34.
https://pubmed.ncbi.nlm.nih.gov/12180122

VI. Bouhafs RKL, Jarstrand C, Robertson B (2002). Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia. [Submitted]

History

Defence date

2002-09-27

Department

  • Department of Laboratory Medicine

Publisher/Institution

Karolinska Institutet

Publication year

2002

Thesis type

  • Doctoral thesis

ISBN-10

91-7349-308-2

Number of supporting papers

6

Language

  • eng

Original publication date

2002-09-06

Author name in thesis

Bouhafs, Rabea K L

Original department name

Department of Immunology, Microbiology, Pathology and Infectious Diseases

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC